Mulay James 4
4 · CG Oncology, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
CG Oncology (CGON) Director James Mulay Receives 9,354-Share Option Grant
What Happened
- James Mulay, a director of CG Oncology, was granted a derivative award (an option) covering 9,354 shares on 2026-06-04. The reported transaction shows $0.00 paid at grant (no cash outlay recorded in the filing). This is a grant/award (transaction code A), not a purchase or sale.
Key Details
- Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (appears to be filed promptly).
- Reported amount: 9,354 shares granted as a derivative award; grant recorded at $0.00 (no cash paid).
- Vesting: 1/12th of the total option vests monthly following June 4, 2026; if the next annual meeting occurs before the first anniversary, any remaining unvested portion vests at that meeting, subject to continuous service (per footnote).
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
- Transaction type: Award/Grant of an option (derivative). No exercise or sale occurred.
Context
- This is a grant of an equity award (option) to an insider, common as part of compensation or retention; it does not represent a market buy or sell. The filing shows no immediate exercise or cashless sale — future value depends on vesting and any exercise terms not shown in the excerpt.
Insider Transaction Report
Form 4
Mulay James
Director
Transactions
- Award
Director Stock Option (right to buy)
[F1]2026-06-04+9,354→ 9,354 totalExercise: $56.09Exp: 2036-06-03→ Common Stock (9,354 underlying)
Footnotes (1)
- [F1]1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for James J. Mulay|2026-06-05